BioHarvest Sciences Inc. ... (BHST)
NASDAQ: BHST
· Real-Time Price · USD
9.32
-0.17 (-1.79%)
At close: Aug 14, 2025, 3:59 PM
9.68
3.85%
Pre-market: Aug 15, 2025, 07:42 AM EDT
BioHarvest Sciences Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.34M | -2.96M | -2.69M | -687K | -6.58M | -7.24M | -1.73M | -2.85M | -752.06K | -2.81M | -3.92M | -2.38M | -2.13M | -1.75M | -3.04M | 1.76M | -6.81M |
Depreciation & Amortization | 399K | 341K | 351K | 356.93K | 201.1K | 216K | 214.24K | 209K | 198K | 192K | 183.1K | 188.38K | 136K | 137.53K | 115.21K | 74.36K | 60K |
Stock-Based Compensation | 132K | 147K | 126K | 195K | 133K | 132K | 118K | 189K | 124K | 345K | 339K | 195K | 473K | 893K | 756K | 1.02M | 694K |
Other Working Capital | 787K | -113K | 1.1M | 311K | -73K | 233K | 823K | -122K | 931K | -82K | 79K | 694K | n/a | 210K | 583K | n/a | n/a |
Other Non-Cash Items | 369K | 458K | 477K | -1.17M | 5.16M | 4.19M | -341K | -138K | -1.83M | 111K | 867K | -155K | -584K | -1.49M | 413K | -4.19M | 4.64M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 11K | -362.19K | -24.11K | 337.87K | -496K | -302.27K | 738K | -295K | 604K | -346K | 24.2K | 403.28K | -402.89K | -77K | 324.2K | -570.24K | 214K |
Operating Cash Flow | -1.43M | -2.39M | -1.76M | -958K | -1.58M | -2.99M | -995K | -2.88M | -1.66M | -2.5M | -2.5M | -1.74M | -2.5M | -2.29M | -1.43M | -1.88M | -1.2M |
Capital Expenditures | -684K | -393K | -512K | -1.71M | -222K | -291K | -440K | -367K | -376K | -266.38K | -279K | -323K | -391K | -354K | -506K | -523K | -257K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 4K | -7K | 40K | -225K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -680K | -400K | -472K | -1.93M | -222K | -291K | -440K | -367K | -376K | -263K | -279K | -323K | -391K | -354K | -506K | -523K | -257K |
Debt Repayment | 3.12M | 2.45M | -164K | -119K | -129K | 13.76M | 1.18M | 4.34M | 617K | 2.27M | 3.1M | n/a | -103K | -103K | -92K | -68K | -69K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -162.22K | -164.69K | -119.08K | -128.42K | -6.61M | 1.17M | 4.41M | 617.05K | -37K | 2.89M | 2M | -104.27K | -101.96K | 2.63M | 18K | 988K |
Financial Cash Flow | 3.12M | 2.45M | -164K | 4.61M | -116K | 7.01M | 1.18M | 4.75M | 617K | 2.23M | 3.83M | 2.03M | 43K | -58.73K | 5.24M | -50K | 5.63M |
Net Cash Flow | 1.01M | -378K | -2.4M | 1.73M | -1.92M | 3.8M | -253K | 1.51M | -1.44M | -536K | 1.06M | -52K | -2.85M | -2.69M | 3.31M | -2.45M | 4.17M |
Free Cash Flow | -2.11M | -2.78M | -2.27M | -2.67M | -1.8M | -3.29M | -1.44M | -3.25M | -2.03M | -2.77M | -2.78M | -2.06M | -2.89M | -2.64M | -1.94M | -2.4M | -1.46M |